The U.S. Food and Drug Administration (FDA) has authorized four significant new cancer drugs in May 2026, marking a pivotal…
Read More
How to tackle the unique pharmacokinetic properties of covalent drugs
The landscape of modern therapeutics has been significantly shaped by covalent drugs, a class of pharmaceuticals distinguished by their ability…
Read More
Pharma 50: The 50 best-selling drugs of FY2025
The pharmaceutical landscape of Fiscal Year 2025 witnessed a dynamic reshuffling at its apex, with Merck’s Keytruda steadfastly holding its…
Read More
Pharma 50: The 50 best-selling drugs of FY2025
The fiscal year 2025 witnessed a dramatic recalibration at the apex of the pharmaceutical industry’s sales leaderboard, characterized by a…
Read More
How to tackle the unique pharmacokinetic properties of covalent drugs
The landscape of modern medicine has been profoundly shaped by therapeutic agents that form stable, enduring bonds with their biological…
Read More
Merck KGaA and Remepy Forge Groundbreaking Partnership to Pioneer "Hybrid Drugs" for Rare Cancers
In a move that signals a significant shift in pharmaceutical innovation, Merck KGaA has announced a strategic collaboration with Remepy,…
Read More
Pharma 50: The 50 Best-Selling Drugs of FY2025
The fiscal year 2025 concluded with a dramatic reshaping of the pharmaceutical industry’s top echelons, marked by intense competition at…
Read More
How to tackle the unique pharmacokinetic properties of covalent drugs
Covalent drugs represent a transformative advancement in medicine, offering unprecedented therapeutic efficacy by forming stable, irreversible bonds with their biological…
Read More
US Government Assumes Full Cost of Weight Loss Drugs for Medicare Beneficiaries Through Extended GLP-1 Bridge Program Amidst Insurer Hesitation
The Centers for Medicare & Medicaid Services (CMS) has announced a significant extension of its Medicare GLP-1 Bridge program, shifting…
Read More
Cochrane Review Challenges Clinical Significance of Anti-Amyloid Alzheimer’s Drugs, Pharmaceutical Companies Reaffirm Efficacy
A comprehensive review of 17 clinical trials by the esteemed Cochrane organization has cast doubt on the clinically meaningful benefits…
Read More
